Treatment with SAR405 inhibited autophagy and suppressed the proliferation of FLT3-ITD-positive AML cell lines, MOLM-14 and MV4-11 cells, in vitro [120]. This evidence concerns the gene FLT3 and acute myeloid leukemia.